周力,陈晖,李卫萍,高红丽,李东宝,赵慧强,姚道阔,李虹伟

• 1:首都医科大学附属北京友谊医院心内科

摘要(Abstract)：

目的总结合并类风湿关节炎(RA)的冠状动脉粥样硬化性心脏病(冠心病)患者冠状动脉病变特点以及接受经皮冠状动脉介入治疗(PCI)术后的院内不良事件发生情况。方法收集2009年1月至2017年6月在首都医科大学附属北京友谊医院接受PCI的69例RA患者的临床资料,回顾性分析RA患者的临床表现、冠状动脉病变特点及住院期间主要不良事件发生情况。结果69例患者中男性11例(15.9%),平均年龄(67.2±13.0)岁,平均SYNTAX评分(31.6±7.2)分。55例(79.7%)患者冠心病传统危险因素≥1个,51例(73.9%)患者为冠状动脉多支血管病变。69例患者共置入145枚支架,其中裸金属支架2枚和药物洗脱支架143枚,50例(72.4%)患者置入了长支架(支架长度>30 mm)。住院期间共25例(36.2%)患者发生主要不良事件,包括心源性死亡1例(1.4%)、支架内血栓2例(2.9%)、PCI相关心肌梗死5例(7.2%)、急性左心衰竭5例(7.2%)、消化道出血4例(5.8%)、对比剂肾病10例(14.5%,包括2例急性左心衰竭患者)。结论合并RA的冠心病患者冠状动脉病变以多支复杂病变为主,此类患者接受PCI后院内不良事件发生率较高,围术期应做到早识别、早预防。

关键词(KeyWords)： 类风湿关节炎;冠状动脉粥样硬化性心脏病;经皮冠状动脉介入治疗

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 周力,陈晖,李卫萍,高红丽,李东宝,赵慧强,姚道阔,李虹伟

参考文献(References)：

• [1]Symmons DP,Gabriel SE.Epidemiology of CVD in rheumatic disease,with a focus on RA and SLE.Nat Rev Rheumatol,2011,7(7):399-408.
• [2]Avina-Zubieta JA,Thomas J,Sadatsafavi M,et al.Risk of incident cardiovascular events in patients with rheumatoid arthritis:a meta-analysis of observational studies.Ann Rheum Dis,2012,71(9):1524-1529.
• [3]Pieringer H,Brummaier T,Schmid M,et al.Rheumatoid arthritis is an independent risk factor for an increased augmentation index regardless of the coexistence of traditional cardiovascular risk factors.Semin Arthritis Rheum,2012,42(1):17-22.
• [4]van den Oever IA,van Sijl AM,Nurmohamed MT.Management of cardiovascular risk in patients with rheumatoid arthritis:evidence and expert opinion.Ther Adv Musculoskelet Dis,2013,5(4):166-181.
• [5]Martín-Martínez MA,Casta?eda S,González-Juanatey C,et al.Cardiovascular risk assessment in rheumatoid arthritis:What goals should be achieved?Semin Arthritis Rheum,2015,44(6):e20-e21.
• [6]Ruscitti P,Cipriani P,Masedu F,et al.Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients:1 year prospective single centre study.PLo S One,2017,12(1):e0170108.
• [7]Lai CH,Lai WW,Chiou MJ,et al.Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus:An 11 year nationwide cohort study.Ann Rheum Dis,2016,75(7):1350-1356.
• [8]Banal F,Dougados M,Combescure C,et al.Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration:a systematic literature review and meta-analysis.Ann Rheum Dis,2009,68(7):1184-1191.
• [9]Ambrosino P,Lupoli R,Di Minno A,et al.Subclinical atherosclerosis in patients with rheumatoid arthritis.A metaanalysis of literature studies.Thromb Haemost,2015,113(5):916-930.
• [10]Hong J,Maron DJ,Shirai T,et al.Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions.Int J Clin Rheumtol,2015,10(5):365-381.
• [11]Faden G,Viapiana O,Fischetti F,et al.Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice:The“EPIDAURO registry”.Int J Cardiol,2014,172(2):534-536.
• [12]Giles JT,Szklo M,Post W,et al.Coronary arterial calcification in rheumatoid arthritis:comparison with the Multi-Ethnic study of atherosclerosis.Arthritis Res Ther,2009,11(2):R36.
• [13]Arida A,Protogerou AD,Konstantonis G,et al.Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission,regardless of antirheumatic treatment modalities.Rheumatology(Oxford),2017,56(6):934-939.
• [14]Mason JC,Libby P.Cardiovascular disease in patients with chronic inflammation:mechanisms underlying premature cardiovascular events in rheumatologic conditions.Eur Heart J,2015,36(8):482-489c.
• [15]陈韵岱,陈纪言,傅国胜,等.碘对比剂血管造影应用相关不良反应中国专家共识.中国介入心脏病学杂志,2014,22(6):341-348.